Longitudinal study of Cystatin C in healthy term newborns

OBJECTIVE: The purpose of this study was to determine the levels of Cystatin C in healthy term newborns in the first month of life. INTRODUCTION: Cystatin C may be a suitable marker for determining the glomerular filtration rate because it is not affected by maternal renal function. METHODS: Cohort study. Inclusion: term newborns with appropriate weight; mother without renal failure or drugs that could affect fetal glomerular filtration rate. Exclusion: malformations; hypertension or any condition that could affect glomerular filtration rate. Cystatin C (mg/L)and creatinine (rng/dl) were determined in the mother (Mo) and in the newborn at birth (Day-0), 3rd (Day-3), 7th(Day-7) and 28t&gt;h(Day-28) days. Statistics: one way ANOVA and Pearson's correlation tests. Sample size of 20 subjects for a = 5% and a power test = 80% (p<0.05). RESULTS: Data from 21 newborns were obtained (mean + standard deviation): MoCystatin C=1.00 ± 0.20; Day-0 Cystatin C 1.70 ± 0.26; Day-3 Cystatin C = 1.51±0.20; Day-7 Cystatin C = 1.54 ± 0.10; Day-28 Cystatin C= 1.51±0.10. MoCystatin C was smaller than Day-0 Cystatin C (p<0.001), while MoCreatinine was not different from Day-0 Creatinine. Cystatin C only decreased from Day-0 to Day-3 (p = 0.004) but newborns Creatinine decreased along the time. Correlations were obtained between MoCystatin C and MoCreatinine (p = 0.012), as well as Day-3 (p = 0.047) and Day-28 (p = 0.022) Cystatin C and Creatinine values. CONCLUSION: Neonatal Cystatin C values were not affected by MoCystatin C and became stable from the 3rd day of life.

Saved in:
Bibliographic Details
Main Authors: Novo,Ana Carolina de Albuquerque Cavalcanti Ferreira, Sadeck,Lilian dos Santos Rodrigues, Okay,Thelma Suely, Leone,Clea Rodrigues
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000200006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322011000200006
record_format ojs
spelling oai:scielo:S1807-593220110002000062011-03-31Longitudinal study of Cystatin C in healthy term newbornsNovo,Ana Carolina de Albuquerque Cavalcanti FerreiraSadeck,Lilian dos Santos RodriguesOkay,Thelma SuelyLeone,Clea Rodrigues Serum Cystatin C Glomerular filtration rate Serum creatinine Reference values Infant newborn OBJECTIVE: The purpose of this study was to determine the levels of Cystatin C in healthy term newborns in the first month of life. INTRODUCTION: Cystatin C may be a suitable marker for determining the glomerular filtration rate because it is not affected by maternal renal function. METHODS: Cohort study. Inclusion: term newborns with appropriate weight; mother without renal failure or drugs that could affect fetal glomerular filtration rate. Exclusion: malformations; hypertension or any condition that could affect glomerular filtration rate. Cystatin C (mg/L)and creatinine (rng/dl) were determined in the mother (Mo) and in the newborn at birth (Day-0), 3rd (Day-3), 7th(Day-7) and 28t&gt;h(Day-28) days. Statistics: one way ANOVA and Pearson's correlation tests. Sample size of 20 subjects for a = 5% and a power test = 80% (p<0.05). RESULTS: Data from 21 newborns were obtained (mean + standard deviation): MoCystatin C=1.00 ± 0.20; Day-0 Cystatin C 1.70 ± 0.26; Day-3 Cystatin C = 1.51±0.20; Day-7 Cystatin C = 1.54 ± 0.10; Day-28 Cystatin C= 1.51±0.10. MoCystatin C was smaller than Day-0 Cystatin C (p<0.001), while MoCreatinine was not different from Day-0 Creatinine. Cystatin C only decreased from Day-0 to Day-3 (p = 0.004) but newborns Creatinine decreased along the time. Correlations were obtained between MoCystatin C and MoCreatinine (p = 0.012), as well as Day-3 (p = 0.047) and Day-28 (p = 0.022) Cystatin C and Creatinine values. CONCLUSION: Neonatal Cystatin C values were not affected by MoCystatin C and became stable from the 3rd day of life.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.66 n.2 20112011-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000200006en10.1590/S1807-59322011000200006
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Novo,Ana Carolina de Albuquerque Cavalcanti Ferreira
Sadeck,Lilian dos Santos Rodrigues
Okay,Thelma Suely
Leone,Clea Rodrigues
spellingShingle Novo,Ana Carolina de Albuquerque Cavalcanti Ferreira
Sadeck,Lilian dos Santos Rodrigues
Okay,Thelma Suely
Leone,Clea Rodrigues
Longitudinal study of Cystatin C in healthy term newborns
author_facet Novo,Ana Carolina de Albuquerque Cavalcanti Ferreira
Sadeck,Lilian dos Santos Rodrigues
Okay,Thelma Suely
Leone,Clea Rodrigues
author_sort Novo,Ana Carolina de Albuquerque Cavalcanti Ferreira
title Longitudinal study of Cystatin C in healthy term newborns
title_short Longitudinal study of Cystatin C in healthy term newborns
title_full Longitudinal study of Cystatin C in healthy term newborns
title_fullStr Longitudinal study of Cystatin C in healthy term newborns
title_full_unstemmed Longitudinal study of Cystatin C in healthy term newborns
title_sort longitudinal study of cystatin c in healthy term newborns
description OBJECTIVE: The purpose of this study was to determine the levels of Cystatin C in healthy term newborns in the first month of life. INTRODUCTION: Cystatin C may be a suitable marker for determining the glomerular filtration rate because it is not affected by maternal renal function. METHODS: Cohort study. Inclusion: term newborns with appropriate weight; mother without renal failure or drugs that could affect fetal glomerular filtration rate. Exclusion: malformations; hypertension or any condition that could affect glomerular filtration rate. Cystatin C (mg/L)and creatinine (rng/dl) were determined in the mother (Mo) and in the newborn at birth (Day-0), 3rd (Day-3), 7th(Day-7) and 28t&gt;h(Day-28) days. Statistics: one way ANOVA and Pearson's correlation tests. Sample size of 20 subjects for a = 5% and a power test = 80% (p<0.05). RESULTS: Data from 21 newborns were obtained (mean + standard deviation): MoCystatin C=1.00 ± 0.20; Day-0 Cystatin C 1.70 ± 0.26; Day-3 Cystatin C = 1.51±0.20; Day-7 Cystatin C = 1.54 ± 0.10; Day-28 Cystatin C= 1.51±0.10. MoCystatin C was smaller than Day-0 Cystatin C (p<0.001), while MoCreatinine was not different from Day-0 Creatinine. Cystatin C only decreased from Day-0 to Day-3 (p = 0.004) but newborns Creatinine decreased along the time. Correlations were obtained between MoCystatin C and MoCreatinine (p = 0.012), as well as Day-3 (p = 0.047) and Day-28 (p = 0.022) Cystatin C and Creatinine values. CONCLUSION: Neonatal Cystatin C values were not affected by MoCystatin C and became stable from the 3rd day of life.
publisher Faculdade de Medicina / USP
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000200006
work_keys_str_mv AT novoanacarolinadealbuquerquecavalcantiferreira longitudinalstudyofcystatincinhealthytermnewborns
AT sadeckliliandossantosrodrigues longitudinalstudyofcystatincinhealthytermnewborns
AT okaythelmasuely longitudinalstudyofcystatincinhealthytermnewborns
AT leoneclearodrigues longitudinalstudyofcystatincinhealthytermnewborns
_version_ 1756432099671277568